Quality of this NR is so much betterThey either hired someone new or spent time on fixing previous issues with their comms. This NR is so much more clearer (the safety data paragraph, what to expect next with BTD, etc). I hope there's a patient advocacy group writing to the FDA to get this approved ASAP.